You are here

  • Home
  • Archive
  • Volume 10, Issue 9
  • TEM8 Tri-specific Killer Engager binds both tumor and tumor stroma to specifically engage natural killer cell anti-tumor activity

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
TEM8 Tri-specific Killer Engager binds both tumor and tumor stroma to specifically engage natural killer cell anti-tumor activity

 

Online download statistics by month:

Online download statistics by month: September 2022 to September 2025

AbstractFullPdf
Sep 202226627278
Oct 2022397415185
Nov 202213313462
Dec 202210510542
Jan 202313713740
Feb 202310811052
Mar 2023838337
Apr 2023939436
May 2023626215
Jun 2023979830
Jul 202310410530
Aug 202314814946
Sep 2023888936
Oct 2023787829
Nov 202311011152
Dec 2023939327
Jan 202410210326
Feb 202412212331
Mar 202415115387
Apr 202415415647
May 202411211333
Jun 2024959447
Jul 202417317756
Aug 202412512622
Sep 202411511539
Oct 202417617846
Nov 202422823126
Dec 202423623736
Jan 202518318325
Feb 202517017044
Mar 202514915148
Apr 202517117144
May 202514414453
Jun 202516316346
Jul 2025220
Sep 2025110
Total487449261553